Engineering Autologous Cell‐Derived Exosomes to Boost Melanoma‐Targeted Radio‐Immunotherapy by Cascade cGAS‐STING Pathway Activation
Small · 2025-01 · 21 (4)
DOI: 10.1002/smll.202408769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 27.11.2024. Verfasst von Fangming Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100…. Hauptthemen laut MEDLINE: Immunotherapy, Exosomes, Nucleotidyltransferases, Melanoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Postdoctoral Fellowship Program of CPSF, National Natural Science Foundation of China, BUCT-CJFH biomedical center.
Abstract (Originalsprache)
Radio‐immunotherapy has offered emerging opportunities to treat invasive melanoma due to its immunostimulatory performances to activate antitumor immune responses. However, the immunosuppressive microenvironment and insufficient response rate significantly limit the practical efficacy. This study presents an autologous cell‐derived exosomes (Exo)‐engineered nanoagonist (MnExo@cGAMP) containing with metalloimmunotherapeutic agent (Mn 2+ ions) and nucleotidyltransferase (2′,3′‐cGAMP, a STING agonist) for boosting melanoma‐targeted radio‐immunotherapy by cascade cGAS‐STING pathway activation. The MnExo@cGAMP can efficiently accumulate in tumor cells due to the autologous targeting performance. Once internalized by tumor cells, the released Mn 2+ ions will enhance stimulator of interferon gene (STING) binding and sensitize cyclic GMP‐AMP (cGAS) to radiotherapy‐induced double‐straned DNA (dsNDA), resulting in amplification of cGAS‐STING pathway activation together with X‐ray irradiation. Meanwhile, loaded 2′,3′‐cGAMP can directly augment pathway activity acting as a secondary messenger. These cascade activations of cGAS‐STING pathway trigger the overexpression of type I interferon, promote dendritic cells (DCs) maturation, antigen presentation, and increase CD8 + T cell activation, resulting effective radio‐immunotherapeutic outcome by overcoming immune‐suppression in melanoma. This study demonstrates a targeted therapeutic modality involving metalloimmunotherapy and agonist for efficient melanoma radio‐immunotherapy by cascade cGAS‐STING pathway activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Organic-Inorganic Composites, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
- The Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing, 100084, P. R. China.
- State Key Laboratory of New Ceramics and Fine Processing, School of Materials Science and Engineering, Tsinghua University, Beijing, 100084, P. R. China.
ORCID-Profile: Wensheng Xie
Förderung
- Postdoctoral Fellowship Program of CPSF
- National Natural Science Foundation of China
- BUCT-CJFH biomedical center
Zitieren
APA
Zhang, F., Zhang, Z., Yang, W., Peng, Z., Sun, J., Li, G., Wei, Y., Wang, X., Zhao, L., & Xie, W. (2025). Engineering Autologous Cell‐Derived Exosomes to Boost Melanoma‐Targeted Radio‐Immunotherapy by Cascade cGAS‐STING Pathway Activation. Small, 21(4). https://doi.org/10.1002/smll.202408769
Vancouver
Zhang F, Zhang Z, Yang W, Peng Z, Sun J, Li G, et al. Engineering Autologous Cell‐Derived Exosomes to Boost Melanoma‐Targeted Radio‐Immunotherapy by Cascade cGAS‐STING Pathway Activation. Small. 2025;21(4). doi:10.1002/smll.202408769
BibTeX
@article{Zhang2025,
author = {Zhang, Fangming and Zhang, Ziyao and Yang, Wanting and Peng, Zhuyuan and Sun, Juntao and Li, Guofeng and Wei, Yen and Wang, Xing and Zhao, Lingyun and Xie, Wensheng},
title = {Engineering Autologous Cell‐Derived Exosomes to Boost Melanoma‐Targeted Radio‐Immunotherapy by Cascade cGAS‐STING Pathway Activation},
journal = {Small},
year = {2025},
volume = {21},
number = {4},
doi = {10.1002/smll.202408769}
}
EUVIMED